In a study investigating c-KIT-positive metastatic uveal melanoma (UM), increased imatinib resistance was observed in cells incubated with either SCF-supplemented medium or microvascular endothelial cells-conditioned medium [144]. Here, KIT is linked to uveal melanoma.